33 Patents
- US124284892025Human PD-L2 Antibodies and Methods of Use Therefor
Board Of Regents, The University Of Texas System
0 cites - US123848472025Cancer Therapy Involving an Anti-pd1 Antibody and a Multi-specific Binding Protein That Binds NKG2D, CD16, and a Tumor-associated Antigen
Dragonfly Therapeutics, Inc.
0 cites - US123848512025Multi-specific Binding Proteins That Bind BCMA, NKG2D and CD16, and Methods of Use
Dragonfly Therapeutics, Inc.
0 cites - US123783182025Proteins Binding NKG2D, CD16 and a Tumor-associated Antigen
DRAGONFLY THERAPEUTICS, Inc.
0 cites - 0 cites
- 0 cites
- US123257472025Human PD-L1 Antibodies and Methods of Use Therefor
Board Of Regents, The University Of Texas System
0 cites - 0 cites
- US122757912025Multi-specific Binding Proteins That Bind HER2, NKG2D, and CD16, and Methods of Use
Dragonfly Therapeutics, Inc.
0 cites - 0 cites
- 0 cites
- US122151572025Multi-specific Binding Proteins That Bind CD33, NKG2D, and CD16, and Methods of Use
Dragonfly Therapeutics, Inc.
0 cites - US121877992025Dual Specificity Antibodies to PD-L1 and PD-L2 and Methods of Use Therefor
Board Of Regents, The University Of Texas System
0 cites - 0 cites
- 0 cites
- 0 cites
- US121346482024Dual Specificity Antibodies to Human PD-L1 and PD-L2 and Methods of Use Therefor
Board Of Regents, The University Of Texas System
0 cites - 0 cites
- 0 cites
- 0 cites
- US119761282024Human PD-L2 Antibodies and Methods of Use Therefor
Board Of Regents, The University Of Texas System
0 cites - 0 cites
- 0 cites
- 0 cites
- 0 cites
- 0 cites
- 0 cites
- 0 cites
- 0 cites
- 0 cites
- 0 cites
- 0 cites
- 0 cites